| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 7/24/2024 | TECX Tectonic Therapeutic | Upgrade | $18.00 | | Strong-Buy | Low |
| 7/24/2024 | IONS Ionis Pharmaceuticals | Upgrade | $51.00 | | Hold ➝ Strong-Buy | Low |
| 7/23/2024 | ALMS Alumis | Upgrade | $12.00 | | Strong-Buy | Low |
| 7/22/2024 | BNTC Benitec Biopharma | Upgrade | $9.00 | | Strong-Buy | Low |
| 7/22/2024 | CELC Celcuity | Upgrade | $19.00 | | Strong-Buy | Low |
| 7/10/2024 | EHC Encompass Health | Upgrade | $92.00 | | Strong-Buy | Low |
| 7/9/2024 | HLVX HilleVax | Downgrade | $2.00 | | Strong-Buy ➝ Hold | Low |
| 7/8/2024 | RVTY Revvity | Upgrade | $115.00 | | Strong-Buy | Low |
| 7/2/2024 | SDGR Schrödinger | Upgrade | $22.00 | | Strong-Buy | Low |
| 6/24/2024 | SLDB Solid Biosciences | Upgrade | $9.00 | | Hold ➝ Strong-Buy | Low |
| 5/21/2024 | QTTB Q32 Bio | Upgrade | $36.00 | | Strong-Buy | Low |
| 5/14/2024 | BOLT Bolt Biotherapeutics | Downgrade | $1.00 | | Strong-Buy ➝ Hold | Low |
| 5/14/2024 | AIRS AirSculpt Technologies | Downgrade | $5.00 | | Strong-Buy ➝ Hold | Low |
| 5/14/2024 | EHAB Enhabit | Upgrade | $10.00 | | Strong Sell ➝ Hold | Low |
| 5/10/2024 | AQST Aquestive Therapeutics | Upgrade | $4.00 | | Strong-Buy | Low |
| 5/8/2024 | MYGN Myriad Genetics | Upgrade | $28.00 | | Market Perform ➝ Outperform | Low |
| 5/6/2024 | BPMC Blueprint Medicines | Upgrade | $112.00 | | Underperform ➝ Market Perform | Low |
| 5/1/2024 | CVS CVS Health | Downgrade | $61.00 | | Outperform ➝ Market Perform | Low |
| 4/30/2024 | LXRX Lexicon Pharmaceuticals | Reiterated Rating | $2.00 | | Outperform | Low |
| 4/29/2024 | DCPH Deciphera Pharmaceuticals | Downgrade | $26.00 | | Outperform ➝ Market Perform | Low |
| 4/29/2024 | XOMA XOMA | Reiterated Rating | $29.00 | | Outperform | Low |
| 4/29/2024 | NGNE Neurogene | Reiterated Rating | $45.00 | | Outperform | Low |
| 4/29/2024 | IMCR Immunocore | Reiterated Rating | $40.00 | | Outperform | Low |
| 4/25/2024 | CVAC CureVac | Downgrade | $4.00 | | Outperform ➝ Market Perform | Low |
| 4/25/2024 | TNDM Tandem Diabetes Care | Upgrade | $40.00 | | Market Perform ➝ Outperform | Low |
| 4/23/2024 | RNAC Cartesian Therapeutics | Reiterated Rating | $17.00 | | Outperform | Low |
| 4/16/2024 | ANAB AnaptysBio | Reiterated Rating | $37.00 | | Outperform | Low |
| 4/15/2024 | MNMD Mind Medicine (MindMed) | Reiterated Rating | $9.00 | | Outperform | Low |
| 4/15/2024 | LENZ LENZ Therapeutics | Reiterated Rating | $24.00 | | Outperform | Low |
| 4/5/2024 | ARDX Ardelyx | Reiterated Rating | $6.00 | | Outperform | Low |
| 4/3/2024 | LRMR Larimar Therapeutics | Reiterated Rating | $10.00 | | Outperform | Low |
| 4/1/2024 | NUVL Nuvalent | Upgrade | $82.00 | | Market Perform ➝ Outperform | Low |
| 3/25/2024 | SGMT Sagimet Biosciences | Reiterated Rating | $3.00 | | Outperform | Low |
| 3/18/2024 | RGLS Regulus Therapeutics | Reiterated Rating | $2.00 | | Outperform | Low |
| 3/14/2024 | SPRB Spruce Biosciences | Downgrade | $1.00 | | Outperform ➝ Market Perform | Low |
| 3/11/2024 | AMLX Amylyx Pharmaceuticals | Downgrade | $2.00 | | Outperform ➝ Market Perform | Low |
| 3/6/2024 | RGNX REGENXBIO | Upgrade | $14.00 | | Market Perform ➝ Outperform | Low |
| 3/5/2024 | SPRY ARS Pharmaceuticals | Upgrade | $11.00 | | Market Perform ➝ Outperform | Low |
| 3/4/2024 | KYTX Kyverna Therapeutics | Reiterated Rating | $10.00 | | Outperform | Low |
| 2/26/2024 | GDRX GoodRx | Reiterated Rating | $9.00 | | Outperform | Low |
| 2/26/2024 | HIMS Hims & Hers Health | Reiterated Rating | $22.00 | | Market Perform | Low |
| 2/26/2024 | ACCD Accolade | Reiterated Rating | $4.00 | | Outperform | Low |
| 2/26/2024 | RCM R1 RCM | Reiterated Rating | $13.00 | | Outperform | Low |
| 2/26/2024 | TDOC Teladoc Health | Reiterated Rating | $9.00 | | Market Perform | Low |
| 2/26/2024 | CERT Certara | Reiterated Rating | $16.00 | | Market Perform | Low |
| 2/26/2024 | WBA Walgreens Boots Alliance | Reiterated Rating | $12.00 | | Market Perform | Low |
| 2/26/2024 | PINC Premier | Reiterated Rating | $21.00 | | Market Perform | Low |
| 2/26/2024 | NVST Envista | Reiterated Rating | $16.00 | | Underperform | Low |
| 2/26/2024 | OMI Owens & Minor | Reiterated Rating | $15.00 | | Market Perform | Low |
| 2/26/2024 | DOCS Doximity | Reiterated Rating | $28.00 | | Market Perform | Low |
| 2/26/2024 | PDCO Patterson Companies | Reiterated Rating | $26.00 | | Outperform | Low |
| 2/26/2024 | XRAY DENTSPLY SIRONA | Reiterated Rating | $26.00 | | Outperform | Low |
| 2/26/2024 | PGNY Progyny | Reiterated Rating | $29.00 | | Outperform | Low |
| 2/26/2024 | CVS CVS Health | Reiterated Rating | $61.00 | | Outperform | Low |
| 2/26/2024 | HSIC Henry Schein | Reiterated Rating | $72.00 | | Market Perform | Low |
| 2/26/2024 | CAH Cardinal Health | Reiterated Rating | $98.00 | | Outperform | Low |
| 2/26/2024 | DGX Quest Diagnostics | Reiterated Rating | $146.00 | | Market Perform | Low |
| 2/26/2024 | LH Laboratory Co. of America | Reiterated Rating | $211.00 | | Outperform | Low |
| 2/26/2024 | COR Cencora | Reiterated Rating | $228.00 | | Outperform | Low |
| 2/26/2024 | IQV IQVIA | Reiterated Rating | $240.00 | | Outperform | Low |
| 2/26/2024 | ALGN Align Technology | Reiterated Rating | $220.00 | | Market Perform | Low |
| 2/26/2024 | MCK McKesson | Reiterated Rating | $600.00 | | Outperform | Low |
| 2/23/2024 | IDYA IDEAYA Biosciences | Reiterated Rating | $42.00 | | Outperform | Low |
| 2/22/2024 | APLT Applied Therapeutics | Reiterated Rating | $5.00 | | Outperform | Low |
| 2/22/2024 | COGT Cogent Biosciences | Reiterated Rating | $10.00 | | Outperform | Low |
| 2/22/2024 | RLAY Relay Therapeutics | Reiterated Rating | $9.00 | | Outperform | Low |
| 2/22/2024 | ARVN Arvinas | Reiterated Rating | $30.00 | | Outperform | Low |
| 2/22/2024 | NUVL Nuvalent | Reiterated Rating | $82.00 | | Market Perform | Low |
| 2/21/2024 | RAPT RAPT Therapeutics | Downgrade | $3.00 | | Outperform ➝ Market Perform | Low |
| 2/20/2024 | BTSG BrightSpring Health Services | Reiterated Rating | $12.00 | | Outperform | Low |
| 2/20/2024 | ENGN enGene | Reiterated Rating | $9.00 | | Outperform | Low |
| 2/9/2024 | SYBX Synlogic | Downgrade | $2.00 | | Outperform ➝ Market Perform | Low |
| 2/7/2024 | AMGN Amgen | Downgrade | $335.00 | | Outperform ➝ Market Perform | Low |
| 2/5/2024 | UTHR United Therapeutics | Reiterated Rating | $338.00 | | Outperform | Low |
| 1/31/2024 | TSVT 2seventy bio | Upgrade | $5.00 | | Market Perform ➝ Outperform | Low |
| 1/30/2024 | NPCE NeuroPace | Reiterated Rating | $8.00 | | Outperform | Low |
| 1/29/2024 | IMNM Immunome | Reiterated Rating | $17.00 | | Outperform | Low |
| 1/23/2024 | PYXS Pyxis Oncology | Reiterated Rating | $4.00 | | Outperform | Low |
| 1/8/2024 | AGL agilon health | Downgrade | $7.00 | | Outperform ➝ Market Perform | Low |
| 12/22/2023 | ALVR AlloVir | Downgrade | $1.00 | | Outperform ➝ Market Perform | Low |
| 12/19/2023 | WVE Wave Life Sciences | Upgrade | $7.00 | | Market Perform ➝ Outperform | Low |
| 12/8/2023 | NBTX Nanobiotix | Reiterated Rating | $5.00 | | Outperform | Low |
| 12/7/2023 | TRML Tourmaline Bio | Reiterated Rating | $18.00 | | Outperform | Low |
| 12/6/2023 | MOR MorphoSys | Reiterated Rating | $18.00 | | Market Perform | Low |
| 11/30/2023 | TNYA Tenaya Therapeutics | Reiterated Rating | $4.00 | | Outperform | Low |
| 11/28/2023 | LXEO Lexeo Therapeutics | Reiterated Rating | $12.00 | | Outperform | Low |
| 11/14/2023 | ABVX ABIVAX Société Anonyme | Reiterated Rating | $12.00 | | Outperform | Low |
| 11/13/2023 | ACRS Aclaris Therapeutics | Downgrade | $1.00 | | Outperform ➝ Market Perform | Low |
| 11/7/2023 | ZNTL Zentalis Pharmaceuticals | Downgrade | $4.00 | | Outperform ➝ Market Perform | Low |
| 10/30/2023 | TSVT 2seventy bio | Downgrade | $5.00 | | Outperform ➝ Market Perform | Low |
| 10/20/2023 | BEAM Beam Therapeutics | Downgrade | $33.00 | | Outperform ➝ Market Perform | Low |
| 10/18/2023 | FDMT 4D Molecular Therapeutics | Upgrade | $18.00 | | Market Perform ➝ Outperform | Low |
| 10/17/2023 | OLK Olink Holding AB (publ) | Downgrade | $26.00 | | Outperform ➝ Market Perform | Low |
| 10/16/2023 | KYMR Kymera Therapeutics | Reiterated Rating | $45.00 | | Market Perform | Low |
| 10/16/2023 | PLRX Pliant Therapeutics | Reiterated Rating | $13.00 | | Outperform | Low |
| 10/16/2023 | TNDM Tandem Diabetes Care | Reiterated Rating | $40.00 | | Market Perform | Low |
| 10/16/2023 | MORF Morphic | Reiterated Rating | $57.00 | | Outperform | Low |
| 10/16/2023 | PRCT PROCEPT BioRobotics | Reiterated Rating | $62.00 | | Outperform | Low |
| 10/16/2023 | VCEL Vericel | Reiterated Rating | $52.00 | | Outperform | Low |
| 10/16/2023 | AXNX Axonics | Reiterated Rating | $68.00 | | Outperform | Low |
